[HTML][HTML] Progress and challenges for malaria vaccines

TL Richie, A Saul - Nature, 2002 - nature.com
Malaria causes much physical and economic hardship in tropical regions, particularly in
communities where medical care is rudimentary. Should a vaccine be developed, it is the …

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

S Liljeqvist, S Ståhl - Journal of biotechnology, 1999 - Elsevier
The first scientific attempts to control an infectious disease can be attributed to Edward
Jenner, who, in 1796 inoculated an 8-year-old boy with cowpox (vaccinia), giving the boy …

DNA vaccines for viral infections: basic studies and applications

HL Robinson, TM Pertmer - 2000 - Elsevier
Publisher Summary This chapter focuses on the basic studies and applications of DNA
vaccines for viral infections. DNA-based vaccines use bacterial plasmids to express protein …

Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection

N Garg, RL Tarleton - Infection and immunity, 2002 - Am Soc Microbiol
Immunity to Trypanosoma cruzi requires elicitation of humoral and cell-mediated immune
responses to extracellular trypomastigotes and intracellular amastigotes. In this study, the …

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

DL Doolan, SL Hoffman - International journal for parasitology, 2001 - Elsevier
The introduction of DNA vaccine technology has facilitated an unprecedented multi-antigen
approach to developing an effective vaccine against complex pathogens such as the …

Aotus monkeys: their great value for anti-malaria vaccines and drug testing

S Herrera, BL Perlaza, A Bonelo… - International journal for …, 2002 - Elsevier
Non-human primates represent a valuable resource for testing potential vaccines
candidates and drugs for human use. Malaria remains one of the greatest burdens for the …

A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys

TJ Kochel, K Raviprakash, CG Hayes, DM Watts… - Vaccine, 2000 - Elsevier
A DNA vaccine that expresses the premembrane/membrane (prM) and envelope (E) genes
of dengue virus serotype-1 was tested for immunogenicity and protection against dengue-1 …

Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques

K Raviprakash, KR Porter, TJ Kochel… - Journal of general …, 2000 - microbiologyresearch.org
A candidate DNA vaccine expressing dengue virus type 1 pre-membrane and envelope
proteins was used to immunize rhesus macaques. Monkeys were immunized …

Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

JC Aguiar, RC Hedstrom, WO Rogers, Y Charoenvit… - Vaccine, 2001 - Elsevier
We compared the needle free jet device device Biojector™ with syringe/needle as a method
to administer a DNA vaccine encoding the Plasmodium falciparum circumsporozoite protein …

[HTML][HTML] Immune Response to a Hepatitis B DNA Vaccine in Aotus Monkeys: A Comparison of Vaccine Formulation, Route, and Method of Administration

RA Gramzinski, CL Brazolot Millan, N Obaldia… - Molecular …, 1998 - Springer
Background Attempts to optimize DNA vaccines in mice include using different routes of
administration and different formulations. It may be more relevant to human use to carry such …